COLLEYVILLE, TX -- (MARKET WIRE) -- 04/24/07 -- digiMedical Solutions, Inc.(TM) (PINKSHEETS: DGMS) today announced it has applied for a Wholesale Distribution License for the company's central Florida facility, located in Naples, Florida. A Wholesale Distribution License will allow the central Harrington's facility to provide physicians, hospitals, and other pharmacies a local place to purchase medication and supplies that they otherwise cannot obtain due to shortages and emergency situations. The license will also provide the company an additional source of sales and revenue.

Susanne Myler, Vice President of Operations, states, "In light of the recent Albuterol inhaler (trade name Proventil®, manufactured by Schering-Plough) shortage and reformulation in December, it became apparent that we needed to assist all the healthcare entities in the area to ensure the health of the population. In that case, our pharmacies were able to obtain a large amount of the inhalers where others were not. Being a localized wholesaler will provide other healthcare entities in the area an additional option for purchasing medications. Additionally, supplies can be obtained that day, rather than having a patient wait 24 hours to receive treatment. In some cases, a 24 hour wait period can create additional health complications. We are happy to provide this service to our patients and colleagues in the Naples area."

digiMedical currently owns and operates four pharmacies in South Florida under the name Harrington's Pharmacies and two pharmacies in Texas with a network of over 35,000 patients. In addition to owning and operating pharmacies in Florida and Texas, digiMedical Solutions is a Microsoft partner which has developed proprietary technologies and processes to digitally streamline the prescription handling process from physician to pharmacy, securely and quickly. digiMedical's technology solution is ideal for managing Schedule II controlled substances to avoid the abuse of such drugs. digiMedical expects to report over $7.5 Million in revenue for 2006, and has forecasted $14.5 million for 2007 revenue.

To be added to digiMedical's corporate e-mail list for shareholders and interested investors, please send an e-mail to ir@digimedical.com.

About Wholesale Distribution

According to the 2006 Florida Statues, Section 499.012.2.6(b), "Wholesale distributor" means any person engaged in wholesale distribution of prescription drugs in or into this state, including, but not limited to, manufacturers; repackagers; own-label distributors; jobbers; private-label distributors; brokers; warehouses, including manufacturers' and distributors' warehouses, chain drug warehouses, and wholesale drug warehouses; independent wholesale drug traders; exporters; retail pharmacies; and the agents thereof that conduct wholesale distributions.

About digiMedical Solutions, Inc.(TM) (www.digiMedical.com)

digiMedical Solutions, Inc.(TM) is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, acquisition of independent pharmacy chains and the sale of select territories to "market partners" licensed to exploit the digiMedical Solutions™ model. digiMedical Solutions, Inc.(TM) currently owns and operates six pharmacies throughout Texas and Florida and is a Microsoft Independent Software Vendor (ISV). digiMedical Solutions'(TM) unique business model connects physicians, patients and pharmacies with next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.

Contact:
digiMedical Solutions, Inc.
Investor Relations
Stasi Turrell
214-722-3029
ir@digimedical.com
www.digimedical.com